None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Determination of the Pharmacokinetics and Oral Bioavailability of Salicylamine, a Potent γ-Ketoaldehyde Scavenger, by LC/MS/MS. Zagol-Ikapitte IA, Matafonova E, Amarnath V, Bodine CL, Boutaud O, Tirona RG, Oates JA, Roberts LJ, Davies SS (2010) Pharmaceutics 2(1): 18-29
    › Citation · 21822464 (PubMed) · PMC3150493 (PubMed Central)
  2. Treatment with a γ-ketoaldehyde scavenger prevents working memory deficits in hApoE4 mice. Davies SS, Bodine C, Matafonova E, Pantazides BG, Bernoud-Hubac N, Harrison FE, Olson SJ, Montine TJ, Amarnath V, Roberts LJ (2011) J Alzheimers Dis 27(1): 49-59
    › Citation · 21709376 (PubMed) · PMC3289064 (PubMed Central)
  3. Isoketals form cytotoxic phosphatidylethanolamine adducts in cells. Sullivan CB, Matafonova E, Roberts LJ, Amarnath V, Davies SS (2010) J Lipid Res 51(5): 999-1009
    › Citation · 19965577 (PubMed) · PMC2853468 (PubMed Central)
  4. Selective gamma-ketoaldehyde scavengers protect Nav1.5 from oxidant-induced inactivation. Nakajima T, Davies SS, Matafonova E, Potet F, Amarnath V, Tallman KA, Serwa RA, Porter NA, Balser JR, Kupershmidt S, Roberts LJ (2010) J Mol Cell Cardiol 48(2): 352-9
    › Citation · 19962379 (PubMed) · PMC2818591 (PubMed Central)